Softwr

Research · head to head

Attest vs Genedata

Attest logo

Attest

Research

Straightforward pricing for predictable research costs

From
On request
Rated
-
Full reviewWebsite
Genedata logo

Genedata

Research

Enterprise R&D data platforms for biologics, screening and bioprocess, owned by Danaher

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Attest pricing is metered by credits, where one credit equals one survey question answered by one person, rather than a flat per seat rate; Genedata there is no entry level and no published price at any tier, so a mid-sized biotech cannot even establish whether Genedata is in its range without a lengthy sales engagement.
  • Prices and features above were last checked on 31 August 2026.

Where they differ

Only the attributes on which Attest and Genedata actually diverge.

Attributes where Attest and Genedata differ
AttributeAttestGenedata
Pricing modelsubscriptionquote
PlatformsWebWeb, On-premise, Private cloud

Identical on both: starting price (On request), free tier (No), user rating (Not yet rated), category (Research).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Attest

Nothing recorded that Genedata does not also cover.

Only in Genedata

  • Screener
  • Biologics
  • Bioprocess
  • Expressionist
  • Selector
  • Profiler
  • Instrument integration
  • GxP-capable deployments

What people use each for

The jobs each tool is most often brought in to do.

Attest

  • Testing product concepts with global audiencesnot Genedata
  • Monitoring brand health across campaignsnot Genedata
  • Validating creative concepts before launchnot Genedata
  • Researching market trends in 70 languagesnot Genedata

Genedata

  • A pharmaceutical screening group processing thousands of plates a week where manual QC and curve fitting no longer scalenot Attest
  • A biologics discovery team linking antibody sequence, expression and assay data across a campaign instead of in spreadsheetsnot Attest
  • A process development group standardising bioprocess run data across sites for modelling and scale-upnot Attest
  • A CRO delivering high-throughput screening results to sponsors that require documented, reproducible analysis pipelinesnot Attest

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Attest

  • Pricing is metered by credits, where one credit equals one survey question answered by one person, rather than a flat per seat rate
  • The Basic tier caps usage at 50,000 credits; going beyond it requires upgrading to Standard (100,000), Elite (200,000) or a custom plan above 400,000
  • Additional credits purchased mid year cost 10 percent more per credit than the plan rate

Genedata

  • There is no entry level and no published price at any tier, so a mid-sized biotech cannot even establish whether Genedata is in its range without a lengthy sales engagement.
  • Platforms are licensed individually and most organisations need two or three, so the real contract is a sum of separate licences plus the integration work between them.
  • Deployment is a services programme rather than an installation, running months and requiring scientific configuration by the vendor, which means value arrives long after the first invoice.
  • Danaher ownership since 2023 gives the roadmap a natural pull toward Danaher instrument and bioprocessing lines, which is an advantage on that hardware and a question to ask if your instrument estate is from competitors.
  • Validated deployments for regulated use add scope, cost and an ongoing revalidation obligation on your side after each vendor release, and that recurring internal effort is rarely counted in the business case.

Pricing, plan by plan

Attest

On request
  • Basic$undefined/mo
    • Up to 50,000 credits
  • Standard$undefined/mo
    • Up to 100,000 credits
  • Elite$undefined/mo
    • Up to 200,000 credits
  • Custom$undefined/mo
    • Over 400,000+ credits

Genedata

On request
  • Genedata platform licence$undefined/year
    • Each platform, such as Screener or Biologics, licensed separately
    • Annual enterprise subscription scoped on users, sites and data volume
    • Implementation and scientific configuration services quoted as a separate programme

Which should you pick?

Choose Attest if

Nothing in the data separates Attest from Genedata on the points above - pick on price and on how each one feels to use.

Attest review

Choose Genedata if

  • You need screener.
  • You work on Web, On-premise, Private cloud.
  • You also want biologics.
Genedata review

Questions people ask

Is Attest or Genedata better?
Neither clearly leads. Attest starts at On request and Genedata at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Attest or Genedata?
Attest starts at On request and Genedata at On request.
Does Attest or Genedata run on more platforms?
Attest runs on Web. Genedata runs on Web, On-premise, Private cloud.
What is Attest best used for?
Attest is most often used for testing product concepts with global audiences, monitoring brand health across campaigns, validating creative concepts before launch, researching market trends in 70 languages. Of those, testing product concepts with global audiences and monitoring brand health across campaigns are not what Genedata is typically brought in for.
What can Attest do that Genedata cannot?
Genedata covers Screener, Biologics, Bioprocess, Expressionist.

Answered from the vendors’ own pages

Attest: How does Attest's credit system work?

Attest uses a credit-based pricing system where one credit equals one survey answer from one respondent. For example, a 10-question survey completed by 500 people uses 5,000 credits. Only respondents who meet survey criteria consume credits from the qualifying question.

Source
Genedata: Who owns Genedata?

Danaher acquired the company in 2023. It remains headquartered in Basel and continues under the Genedata name.

Attest: What plans does Attest offer?

Attest offers four subscription plans: Basic (up to 50,000 credits), Standard (up to 100,000 credits), Elite (up to 200,000 credits), and Custom (over 400,000+ credits). All plans include unlimited user seats, designated research expert, customer success team support, and access to 150+ million consumers across 59 countries in 70+ languages.

Source
Genedata: Is there a small-team or starter option?

No. Everything is an enterprise contract scoped by users, sites and data volume, with services attached.

Attest: Can I purchase additional credits on Attest?

Yes. Additional credits are available as add-ons throughout the year. Add-on credits cost 10% more than the per-credit rate in annual plans.

Source
Genedata: Do I buy one product or the whole suite?

Each platform is licensed separately. Most customers license two or three and integrate between them.

Genedata: Can it be used in a GxP environment?

Yes, with a validated deployment contracted as additional scope. Ongoing revalidation after releases remains your responsibility.

Share

Related pages

More on Attest

More on Genedata

Keep looking

Other head to heads